Background: Retrobulbar anesthesia is widely used for ocular surgery.
INTRODUCTION
Although topical and intraocular anesthesia have been successfully used for several types of ocular surgery, most commonly for phacoemulsification, 1 retrobulbar anesthesia is still widely used at many institutions. Direct trauma to the eye (eg, optic nerve damage, scleral perforation) occurs in <1 in 1000 retrobulbar injections worldwide. 2 Severe ocular complications have been reported in cases of accidental intravitreal injection of anesthetic agents. [3] [4] [5] Moreover, intravitreal application of local anesthetics has been shown to have toxic effects on the retina in vitro. 6 Ropivacaine hydrochloride is a long-acting local anesthetic agent that has a greater margin of safety in terms of cardiac and central nervous system toxicity compared with bupivacaine. T The efficacy and safety of ropivacaine for retrobulbar, peribulbar, and topical anesthesia during cataract surgery have been well studied. [8] [9] [10] [11] [12] We have previously shown that the application of 1% ropivacaine to the anterior chamber results in endothelial changes in the cornea in a rat model. 13
Based on a PubMed search (key terms: retina, ropivacaine, and toxicity; years: 1965-2005) , the present study is the first report of the effects of ropivacaine on the retina.
Because of the potential for posterior diffusion of anesthetics when they are administered into the anterior segment or accidentally injected intravitreally, the objective of the present study was to determine the effects of ropivacaine on the retina in a guinea pig model.
MATERIALS AND METHODS
This randomized, investigator-masked, experimental study was conducted at the Department of Anesthesiology, Dicle University, Diyarbakir, Turkey. Eighteen guinea pigs that were healthy and free of clinical ocular disease were used in this study. All procedures were performed according to the Association for Research in Vision and Ophthalmology Statement 14 for the use of animals in ophthalmic and vision research, and the approval of the Committee on Animal Research of Dicle University was obtained.
The right eyes of the guinea pigs were randomly assigned, using a computergenerated list of random numbers, to receive 1%, 0.75%, or 0.5% ropivacaine (6 eyes per group). All animals were anesthetized with an IM injection of a mixture of ketamine hydrochloride 50 mg/kg and xylazine hydrochloride 10 mg/kg. The right eye of each animal was injected approximately in the middle of the vit-reous cavity (by performing the injection when the needle tip was seen from the pupilla) with 0.1 mL of 1%, 0.75%, or 0.5% ropivacaine. The left eyes were similarly injected with 0.1 mL of balanced saline solution (BSS) (control). Retinas were assessed 7 days after intravitreal injection of ropivacaine, as previously described. 15 The animals were then euthanized using an overdose of anesthetic, and the eyes were enucleated. 14 The specimens were dehydrated in a graded ethanol and xylene series and then embedded in paraffin. Sections of the retina (4-1Jm thickness) were obtained from 2 distinct locations. The sections were stained with hematoxylin and eosin, and the histopathologic changes were evaluated using light microscopy. Measurements were taken, in increments of 100 IJm, to a range of 800 to 1200 IJm above and below the optic nerve head, according to a previously described method. 16 The investigators who examined the specimens and measured retinal thickness were masked to treatment assignment.
Statistical Analysis
The Kruskal-Wallis and Hollander-Wolfe 1~ multiple comparison tests were used sequentially for the analysis of the differences in mean total retinal thicknesses between treatments. Statistical analyses were not performed for the thicknesses of the retinal layers, and no power analysis was performed. Values were presented as mean (SD). A P value <0.05 was considered statistically significant.
RESULTS
The figure shows light microscopy of retinas representative of each group 7 days after injection in the vitreous cavity. The appearance of the retinas of the control eyes (injected with BSS) was normal, and no histologic abnormalities were observed ( Figure; part A). In the drug-injected eyes, retinal damage of most of the retinal sections was seen. The destruction of the retinal structure was more severe in the eyes receiving 1% ropivacaine compared with those receiving 0.75% or 0.5% ropivacaine ( Figure; part B). In all 6 eyes injected with 1% ropivacaine, the internal limiting membrane was completely absent and the retinal ganglion cell layer had lost its regular structure. Histopathologic differences such as atrophy, disorganization, and destruction were seen at the inner and outer plexiform layers, the inner and outer nuclear layers, and the outer limiting membrane (Figure; part B) .
All of the eyes injected with 0.75% ropivacaine exhibited destruction and loss of tissue in the retinal structure, including the inner limiting membrane, ganglion cell layer, plexiform layers, and outer nuclear layer (Figure; part C). The eyes injected with 0.5% ropivacaine had a generally intact appearance, with the exception of some atrophy and disorganization (Figure; part D) .
The mean measurements of total thickness of the retina are shown in the table. Mean thickness was significantly less in all 3 ropivacaine-treated groups compared with that in the control group (all, P < 0.001). The eyes injected with 1% ropivacaine showed significantly more extensive retinal thinning compared with the groups injected with 0.75% or 0.5% ropivacaine (both, P < 0.01).
DISCUSSION
Based on our literature search, there have been many experimental investigations of the toxic effects of the intravitreal application of lidocaine and bupivacaine, 2 agents widely used for retrobulbar and peribulbar anesthesia. 6,IS,Is,19 However, our search revealed no studies evaluating the toxic effects of ropivacaine on the retina. Several in vitro studies have suggested that lidocaine might be toxic to the retina. ~,2°,21 Grosskreutz et al ~ examined the effects of lidocaine on rat retinal ganglion cells (RGCs) in vitro and in a modified in vivo assay and found that lidocaine exhibited dose-dependent toxicity for RGCs in vitro. Lower concentrations (0.5 and 1.0 mM) of lidocaine were nontoxic; however, 2.0, 6.0, and 12.0 mM of lidocaine killed 25%, 88%, and 99% of the RGCs, respectively. The investigators also found that intravitreal lidocaine was toxic to RGCs in a dosedependent manner in the in vivo assay; lidocaine concentrations of 3.0, 7.5, and 15 mM killed 25%, 38%, and 44% of the RGCs, respectively.
Mondragon and Frixione 2° found that in vitro lidocaine might interfere with the dark-adapting migration of screening pigments in crayfish photoreceptors and within the cells of the frog retinal pigment epithelium. The lidocaineinduced inhibition of dark adaptation was reversible and dependent on the levels of calcium and sodium in the interstitial and intracellular fluids.
In a study by Chebabo et al, 2z isolated chick retinas exposed to lidocaine (3-7 mM) in vitro for 30 minutes had a dose-dependent decrease in propagation, amplitude, and duration of the slow potential change of spreading depression.
Liang et al z5 determined that intravitreal injection of 0.2 mL of 0.25% to 2% lidocaine, 0.25% to 0.75% bupivacaine, or a mixture of 2% lidocaine and 0.75% bupivacaine induced reversible changes in the electroretinograms (ERGs) of rabbit retinas but produced no permanent histologic abnormalities. Similarly, Anders et a122 evaluated the effect of intracameral injection of 0.15 mL of 1% lidocaine on the ERG in humans compared with controls receiving peribulbar injection of prilocaine. The ERGs of 15 patients and 15 controls were evaluated preoperatively and 40 minutes postoperatively. There was a decrease in the b-wave amplitude 40 minutes postoperatively in both groups, but no significant between-group differences in implicit times or amplitudes on the ERGs were found. Nishide et a119 reported that rabbit corneas and retinas manifested no serious functional or histologic changes after the injection of lidocaine at concentrations <0.2%. Likewise, Zemel et al is found that lidocaine and bupivacaine were nontoxic to the rabbit retina at concentrations that are effective for retrobulbar anesthesia in clinical use.
Clinical reports have also shown transient and permanent adverse effects induced by lidocaine. Hoffman and Fine 3 reported a case of sudden complete loss of visual acuity after an intracameral injection of 1% lidocaine. Lincoff et al 4 presented details of 3 patients who received intraocular lidocaine inadvertently. The first patient had not received a mydriatic, and the lidocaine caused immediate dilatation and paralysis of the pupil and diminished visual acuity for the ability to count fingers. Retinal function began to improve after 4 hours, and both retinal and pupillary functions recovered completely within 16 hours. The second patient also recovered completely. However, a permanent field defect developed in the third patient. The investigators subsequently examined the effects of intraocular lidocaine in an animal model and found that lidocaine temporarily paralyzed the pupil in mydriasis and temporarily extinguished the b-wave seen on ERG.
In the present study, ropivacaine induced concentration-dependent histologic changes and retinal thinning in guinea pigs. A limitation of this study might be that the histologic examination was done only 7 days after drug injection. The earlier and later retinal changes could be investigated to determine a wider range of changes. Functional tests are needed to determine the significance of retinal thinning. Further studies using various drug concentrations, ERGs, and electron microscopy are needed to better evaluate the functional correlates of the histopathologic changes observed in the present study.
CONCLUSIONS
This experimental study showed that at concentrations >0.5% ropivacaine injected intravitreally was associated with histopathologic changes in the retinas of guinea pigs.
